Evidence map›Paper›PMID 29082676›Full record

ReviewEuropean journal of heart failure2018

Lessons learned in acute heart failure.

Baljash Cheema, Andrew P Ambrosy, Rachel M Kaplan, Michele Senni, Gregg C Fonarow, Ovidiu Chioncel, Javed Butler, Mihai Gheorghiade

Abstract readReview
In one paragraph

Review in European journal of heart failure, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Heart rate and blood pressure monitoring in heart failure.European heart journal supplements : journal of the European Society of Cardiology · 2019
    Article
  16. Review
  17. Repetitive levosimendan treatment in the management of advanced heart failure.European heart journal supplements : journal of the European Society of Cardiology · 2018
    Article
  18. Mihai Gheorghiade, MD-Life and Concepts.American journal of therapeutics
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Baljash CheemaNorthwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Andrew P AmbrosyDuke University Medical Center, Durham, NC, USA.
Rachel M KaplanNorthwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Michele SenniCardiovascular Department, Papa Giovannni XXIII Hospital, Bergamo, Italy.
Gregg C FonarowAhmanson-UCLA Cardiomyopathy Center, Ronald Reagan-UCLA Medical Center, Los Angeles, CA, USA.
Ovidiu ChioncelInstitute of Emergency for Cardiovascular Diseases 'Prof. C.C. Iliescu', Cardiology 1, UMF Carol Davila, Bucharest, Romania.
Javed ButlerStony Brook University, Stony Brook, NY, USA.
Mihai GheorghiadeNorthwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Northwestern University · USCarol Davila University of Medicine and Pharmacy · ROClinical Research Institute · USOspedale Papa Giovanni XXIII · ITRonald Reagan UCLA Medical Center · USStony Brook University · US

Funding

Postdoctoral Training in Cardiovascular Clinical ResearchT32HL069749 · NHLBI · DUKE UNIVERSITY · PI MARK, DANIEL B · 2003 to 2023
$6.7M
NHLBI NIH HHS T32 HL069749
6 · The paper itself

Abstract

Acute heart failure (HF) is a global pandemic with more than one million admissions to hospital annually in the US and millions more worldwide. Post-discharge mortality and readmission rates remain unchanged and unacceptably high. Although recent drug development programmes have failed to deliver novel therapies capable of reducing cardiovascular morbidity and mortality in patients hospitalized for worsening chronic HF, hospitalized HF registries and clinical trial databases have generated a wealth of information improving our collective understanding of the HF syndrome. This review will summarize key insights from clinical trials in acute HF and hospitalized HF registries over the last several decades, focusing on improving the management of patients with HF and reduced ejection fraction.

Indexed as

RegistriesAcute DiseaseGlobal HealthHeart FailureHospitalizationHospital MortalityHumansMorbidityPrognosisSurvival RateAcute heart failureClinical trialRegistry

Identifiers

PMID29082676
PMCPMC6677242
OpenAlexW2765934668

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.